Page 31 - Read Online
P. 31
Page 321 Guerra et al. J Transl Genet Genom 2022;6:304-21 https://dx.doi.org/10.20517/jtgg.2022.08
Pharmacogenet Genomics 2008;18:761-72. DOI PubMed
80. Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor
antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane
Database Syst Rev 2013;5:CD002095. DOI PubMed PMC
81. Addington WR, Stephens RE, Gilliland K, Miller SP. Tartaric acid-induced cough and the superior laryngeal nerve evoked potential.
Am J Phys Med Rehabil 1998;77:523-6. DOI PubMed
82. Ward RM, Kearns GL. Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and
pharmacodynamics. Paediatr Drugs 2013;15:119-31. DOI PubMed PMC
83. Rouby N, Lima JJ, Johnson JA. Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine. Expert Opin Drug
Metab Toxicol 2018;14:447-60. DOI PubMed PMC
84. Harris DM, Stancampiano FF, Burton MC, et al. Use of pharmacogenomics to guide proton pump inhibitor therapy in clinical practice.
Dig Dis Sci 2021;66:4120-7. DOI PubMed
85. Patial RK. Baclofen in the treatment of intractable hiccups. J Assoc Physic India 2002;50:1312-3.
86. McLaughlin MJ, He Y, Brunstrom-Hernandez J, et al. Pharmacogenomic variability of oral baclofen clearance and clinical response in
children with cerebral palsy. PMR 2018;10:235-43. DOI PubMed PMC
87. Ferrier J. Domperidone as an unintended antipsychotic. Can Pharm J (Ott) 2014;147:76-7. DOI PubMed PMC
